nded randomized clinical trial of acute rejection in cadaveric renal transplantative. Transplantation,1996,61:1029-1037. 14 Sollinger HW, US Renal Transplant Mycophenolate mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation，1995,60:225-232.
15 Bradley J, Bloom, MD. New drug therapies for the pediatric theumatic rheumatic disease. Current Opinion in Rheumatology,2001,13:410-414.
16 Buratti S, Szer IS, Spencer CH, et al. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus. J Rheumatol,2001,28:2103-2108.
17 Filler G, Hansen M, LeBlanc C, et al. Pharmacokinetics of mycophenolate mofetil for autoimmune desease in children. Pediatr Nephrol,2003,18:445-449.
18 Imundo L. Three year followup of mycophenolate mofetil therapy in childhood SLE continued effectiveness as a maintenance agent. Ped Theum Online J,2003,2：104.
作者单位： 200001 上海，上海交通大学医学院附属仁济医院儿科
上一页 [1] [2] [3] [4]
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文